Stay updated on Pembrolizumab for Genomic Instability Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision line was updated to v3.6.4, indicating a software release rather than changes to study details. This appears to be a backend update without substantive changes to the trial information.
    Difference
    0.1%
    Check dated 2026-07-27T06:35:58.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now reflects a newer revision label (v3.6.3) replacing the previous one (v3.6.2), indicating an updated version of the study documents.
    Difference
    0.1%
    Check dated 2026-07-05T14:30:34.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Updated Study Documents section now lists the Informed Consent Form (2022-05-11) and Study Protocol/Statistical Analysis Plan (2023-02-22), and adds IPD sharing information and expanded metadata/MeSH terms.
    Difference
    59%
    Check dated 2026-06-28T08:33:55.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Study Plan header to Intervention/Treatment, while removing the older header spacing and bumping the revision version to v3.6.0. The recruitment status was changed to no longer recruiting, affecting enrollment availability.
    Difference
    0.4%
    Check dated 2026-06-14T07:38:58.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Updated the document revision from v3.5.4 to v3.5.5 in the Study Plan documents. This indicates a newer version of the protocol and SAP is now referenced on the page.
    Difference
    0.1%
    Check dated 2026-06-07T04:21:29.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.3 to v3.5.4, indicating a minor page update; no changes to the study data or eligibility criteria are indicated.
    Difference
    0.1%
    Check dated 2026-05-16T19:43:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.